As of 2025-05-18, the Intrinsic Value of Xiamen Amoytop Biotech Co Ltd (688278.SS) is 43.72 CNY. This 688278.SS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 73.03 CNY, the upside of Xiamen Amoytop Biotech Co Ltd is -40.10%.
The range of the Intrinsic Value is 33.14 - 65.95 CNY
Based on its market price of 73.03 CNY and our intrinsic valuation, Xiamen Amoytop Biotech Co Ltd (688278.SS) is overvalued by 40.10%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 33.14 - 65.95 | 43.72 | -40.1% |
DCF (Growth 10y) | 62.99 - 128.20 | 84.11 | 15.2% |
DCF (EBITDA 5y) | 128.56 - 167.72 | 148.23 | 103.0% |
DCF (EBITDA 10y) | 173.80 - 251.29 | 210.57 | 188.3% |
Fair Value | 54.14 - 54.14 | 54.14 | -25.87% |
P/E | 54.91 - 70.03 | 62.60 | -14.3% |
EV/EBITDA | 38.43 - 72.91 | 60.30 | -17.4% |
EPV | 8.20 - 10.49 | 9.34 | -87.2% |
DDM - Stable | 16.75 - 45.37 | 31.06 | -57.5% |
DDM - Multi | 41.53 - 87.37 | 56.30 | -22.9% |
Market Cap (mil) | 29,708.60 |
Beta | 0.49 |
Outstanding shares (mil) | 406.80 |
Enterprise Value (mil) | 29,356.03 |
Market risk premium | 6.13% |
Cost of Equity | 10.17% |
Cost of Debt | 5.00% |
WACC | 10.17% |